Chronic Liver Disease. Burden Markedly decreased life expectancy 12th leading cause of death in US 25,000 deaths annually in US High morbidity and mortality.

Slides:



Advertisements
Similar presentations
Learning objectives To understand the pathophysiologic basis for vasoactive therapies for HRS To become familiar with the diagnostic criteria for HRS To.
Advertisements

Hepatocirrhosis Liver cirrhosis.
Approach to a patient with jaundice
Chronic Liver Disease Simon Lynes. Definition Progressive destruction and regeneration of the liver parenchyma leading to fibrosis and cirrhosis.
Teaching Liver cirrhosis with varices. Discussion  Approximately half of patients with cirrhosis have esophageal varices  One-third of all patients.
MAZEN HASSANAIN PORTAL HYPERTENSION. CAUSES Cirrhosis Non-cirrhosis.
Body Fluids and Infectious Complications. Body Fluids Intracellular Extracellular Plasma (fluid component of blood) Interstitial fluid (surrounds the.
Management of ascites in patients with cirrhosis Treviso 4 Giugno 2009 P. Angeli Dept. of Clinical and Experimental Medicine University of Padova.
Steve Bradley Chief Medical Resident, HMC Inpatient Services
Approach to peritoneal fluid analysis Dr Yasir M Khayyat Assistant Professor,Consultant Gastroenterologist Umm AlQura University.
Liver Function Tests (LFTs)
For final year medical students 2014 Dr Rosalind Pool GPST1
Cirrhosis Biol E-163 TA session 1/8/06. Cirrhosis Fibrosis (accumulation of connective tissue) that progresses to cirrhosis Replacement of liver tissue.
CLINICAL CHEMISTRY-2 (MLT 302) LIVER FUNCTION AND THE BILIARY TRACT LECTURE FIVE Dr. Essam H. Aljiffri.
CDI Education Cirrhosis 4/17/2017.
Complications of Liver Cirrhosis Ayman Abdo MD, AmBIM, FRCPC.
Cirrhosis of the Liver Kayla Shoaf.
Liver pathology: CIRRHOSIS
PORTAL HYPERTENSION & CHRONIC LIVER DISEASE SEAN CHEN ST GEORGE HEPATOBILIARY & PANCREATIC WORKSHOP 31/05/2014.
Cirrhosis of Liver: Continuation Nursing 2015 Part two 22 to 42slides.
Approach to medical liver biopsies Dr Behrang Mozayani Consultant Histopathologist Southmead hospital Bristol.
Alcohol and Abnormal Blood Tests Dr Steve Brinksman Dr Martyn Hull.
Fatty Liver and Pregnancy Shahin Merat, M.D. Professor of Medicine Digestive Disease Research Institute Tehran University of Medical Sciences 1.
CIRRHOSIS OF LIVER PORTAL HYPERTENSION HEPATIC ENCHEPALOPATHY
HEPATO renal Syndrome Type I: Correct Diagnosis = Correct Management Stephen G. M. Wong BSc, BSc(Med), MD, MHSc, FRCPC Associate Professor of Medicine.
Cholestatic liver diseases:
ASCITES IT IS THE CONDITION OF PATHOLOGICAL ACCUMULATION OF FLUID IN ABDOMINAL CAVITY.
Clinical Pathological Conference Mack C. Mitchell, Jr., M.D. Johns Hopkins Bayview Medical Center February 2, 2010.
CASE PRESENTATION DR NADIA SHAFIQUE. CASE SUMMARY  38 yrs old female GULSHAN diagnosed case of HCV related DCLD (child class C) CTP score 11presented.
Liver Function Tests. Tests Based on Detoxification and Excretory Functions.
Other causes of Cirrhosis: Genetic eg. Wilson's Disease, Hemochromatosis Autoimmune eg. Autoimmune Hepatitis, Primary Biliary Cirrhosis, Primary Sclerosing.
Cirrhosis 18 November 2009 Thomas C Sodeman MD Associate Professor of Medicine Chief, Division of Gastroenterology.
Evaluating the Patient With Abnormal Liver Tests-2 פרופ ' צבי אקרמן מבית חולים הדסה הר הצופים.
INTERFERENCE TO NUTRITIONAL NEEDS DUE TO DEGENERATION AND INFLAMMATION Cirrhosis and Hepatitis.
Cirrhoses And Its Complications Ahmad Shavakhi.
Spontaneous Bacterial Peritonitis Katherine Yu May 2014.
Portal Hypertension Mazen Hassanain.
C IRRHOSIS. A LCOHOLIC L IVER I NJURY : Alcoholic Liver disease - Patterns Fatty change, Acute hepatitis Chronic hepatitis Cirrhosis, Chronic Liver failure.
ASCITES & PERITONITIS.
A 57-year-old man presents with fatigue for several months. He underwent a blood transfusion with several units in 1982 after car accident. Physical examination.
Dr. Ravi kant Assistant Professor Department of General Medicine.
Complications of Liver Cirrhosis
Cirrhoses And Its Complications Ahmad Shavakhi.MD Associate professor of gastroenterology.
*Transudate (
Liver function Tests What are liver tests? Liver tests (LTs) are blood tests used to assess the general state of the liver or biliary system. Few of these.
Steve Bradley Chief Medical Resident, HMC Inpatient Services.
Ascites The Aim Is To Approach The Patient With Ascites In Terms Of :
Ascites 소화기내과 F1 김경엽.  Ascites: pathologic accumulation of fluid in the peritoneal cavity Causes of ascitesPercentage Cirrhosis81 % Cancer10 % Heart.
Definition  Is a chronic disease characterized by scaring and necrotic tissue replaced by fibrotic tissue. Resulting in hepatic insufficiency and portal.
Presentation by JoAnn Czech RN/CDS St. Cloud Hospital.
Chronic liver disease Multiple causes, common manifestation.
CIRRHOSIS MANAGEMENT FOR HOSPITALISTS Madhav Devani 6/7/16.
Intern Report Patient Presentation  55yM no PMH presenting with worsening abdominal pain for 2-3 days. Describes pain as diffuse, non-radiation,
Approach to Ascites Updated by Daniel Kim, 06/2017.
Raymond A Rubin, MD 5 March 2015
Liver Disease tutoring Part 2
Liver Function Tests.
ASCITES By Dr WAQAR MBBS, MRCP Asst. Professor Maarefa College.
Managing Complications of Cirrhosis
Spontaneous Bacterial Peritonitis
Multiple factors can predispose to decompensation in a patient with cirrhosis. Risk factors for decompensation include: Bleeding Infection Alcohol.
Liver “Function” Test 2013 Mini-Lecture
Fluid Analysis.
Vandana Khungar, Sammy Saab  Clinical Gastroenterology and Hepatology 
Andres Cardenas, Pere Ginès  Journal of Hepatology 
Internal medicine L-4 Liver cirrhosis & portal hypertension
Cirrhosis with ascites-consider pt for liver transplant
LFTs and Bloods Laz.
LIVER CIRRHOSIS IN PSC: DIAGNOSIS AND MANAGEMENT
Presentation transcript:

Chronic Liver Disease

Burden Markedly decreased life expectancy 12th leading cause of death in US 25,000 deaths annually in US High morbidity and mortality due to complications

Cirrhosis Alcoholic liver disease Chronic hepatitis B Chronic hepatitis C Primary biliary cirrhosis Primary sclerosing cholangitis Autoimmune hepatitis Hereditary hemochromatosis Wilson’s disease Alpha1-antitrypsin deficiency Hepatic Fibrosis

Hepatic fibrosis Fibrosis is a wound healing response in which damaged regions are encapsulated by an extracellular matrix or scar Develops in almost all patients with chronic liver injury

Cirrhosis Late stage of progressive hepatic fibrosis Generally irreversible in advanced stages

LFT’s LFT is a misleading term – Does not reflect how well the liver is functioning – Abnormal values can be caused by non-hepatic diseases

LFT’s Enzyme tests: AST, ALT, Alk Phos and GGT Hepatic Function: Albumin and PT and Indirect bilirubin Hepatic transport ability (biliary system): Direct Bilirubin

Patterns Disproportionate elevation of transaminases seen with hepatocellular processes Disproportionate elevation of Alk Phos seen in cholestatic process Serum Bilirubin can be elevated in both processes, so need to look at direct vs indirect bilirubin to differentiate

Patterns Low albumin suggests chronic process Normal albumin suggests acute process Elevated PT/INR is either Vit K deficiency (due to malabsorption of Vit K) or significant hepatocellular dysfunction (inability to make coagulation factors) Failure of parenteral Vit K to correct PT indicates significant hepatocellular dysfunction (inability to make coagulation factors).

Patients who lack an apparent cause for cirrhosis should be questioned about lifetime body weight because nonalcoholic steatohepatitis (NASH) has been concluded to be causative in many patients.

Ascites What do we do when a patient presents with ascites for the first time?

The cause of new ascites should be evaluated by doing a paracentesis.

What does a bloody ascitic fluid suggest?

Tumor

What does a cloudy ascitic fluid suggest?

Infection

What does a milky ascitic fluid suggest?

Lymphatic obstruction

Approximately 1,500cc of fluid must be present in the abdomen before flank dullness is detected on percussion. The fluid wave is not a useful sign but shifting dullness is.

What is the most common cause of ascites in United States?

85% of patients with ascites in the United States have cirrhosis

What are the tests that we order on the ascites fluid obtained by paracentesis?

IF uncomplicated cirrhosis ascites is suspected, only cell count and differential, albumin, and total protein concentration are performed on the initial specimen.

If ascitic fluid infection is suspected (fever, abdominal pain, elevated cell count or unexplained encephalopathy), bacterial culture in blood culture bottles should be performed.

What can we do to determine the cause of ascites after the ascitic fluid labs are back?

Serum-to ascites albumin gradient (SAAG) SAAG= (serum albumin)-(ascitic fluid albumin) SAAG > 1.1 indicates portal HTN SAAG < 1.1 indicates pt does not have portal HTN

SAAG >1.1 (portal HTN): -Cirrhosis -Right heart failure -Fulminant liver failure (which also includes “massive hepatic metastasis”) -Budd-Chiari syndrome -myxedema

SAAG<1.1: -TB peritonitis -Nephrotic syndrome -Pancreatitis -Peritoneal carcinomatosis

Elevated ascites protein level >=2.5 is seen in all cases of SAAG<1.1 but also in right heart failure.

Ascites PMN count >250 is infection until proven otherwise. -Do bacterial culture in “blood culture bottles” -Is considered to be spontaneous bacterial peritonitis (SBP) if there is no evidence of intra-abdominal, surgical treatable source of infection (secondary bacterial peritonitis).

Most of the bacterial cultures of ascitic fluids with PMN>250 will grow bacteria if: 1)The fluid is cultured in two blood culture bottles 2)There has been no prior antibiotic treatment and 3)There is no other explanation for an elevated PMN count (e.g. hemorrhagic ascites, peritoneal carcinomatosis, pancreatitis, or peritoneal TB).

Patients who meet the criteria explained on the previous slide but have negative cultures have been labeled with diagnosis of “culture- negative neutrocytic ascites and should be treated as if they have SBP due to similar mortality as SBP if not treated as such.

Diagnosis of SBP Definition: ascitic fluid infection w/o intra- abdominal source of infection Positive ascitic fluid culture and/or PMN>250 Consider secondary bacterial peritonitis if at least two of the following: – TP >1.0 – Glucose <50 – LDH > upper limit for serum AND multiple organisms growing on gram stain or culture. AND PMN >250 (sometimes in thousands).

Antibiotic choice Need to cover gut flora as well as Strep and Staph 3 rd generation cephalosporin such as cefotaxime 2g IV q8hrs Treat for 5 days and reassess patient – If has had good response, d/c antibiotics – If still has fever or abd pain, re-tap PMN <250, stop antibiotics PMN > pre-treatment level, look for surgical cause PMN >250 but < pre-treatment level, give 48 hrs antibiotocs and repeat tap

SBP Prophylaxis Indicated for patients with h/o SBP or variceal bleed Proven to decrease mortality, to prevent bacterial infections, and to be cost effective

SBP Prophylaxis Regimens If h/o SBP, Norfloxacin 400 mg qweek or Bactrim DS qday If recent variceal bleed, Norfloxacin 400 mg BID or Bactrim DS BID for 7 days

Treatment of ascites of liver disease Goal is to minimize edema and ascites w/o intravascular volume depletion No evidence that treatment of ascites improves survival, but pt’s feel better Treat underlying disorder (eg: Alcohol cessation for alcoholic cirrhosis) Avoid NSAID’s Limit Na to 2g/day

Treatment of ascites of liver disease (continued) It is Na restriction and not fluid restriction that results in weight loss Fluid restriction is not necessary in treating most patients with cirrhosis or ascites Do not attempt to correct the chronic hyponatremia (which is seen often in cirrhotic patients with ascites) unless < since attempts to rapidly correct hyponatremia with saline can lead to more complications than the hyponatremia itself.

Treatment of ascites of liver disease (continued) Start with combination of spironolactone and furosemide (100 mg and 40mg) or spironolactone alone Max required doses: spironolactone 400mg/d and furosemide 160 mg/d If using combination of spironolactone and furosemide, keep spironolactone to furosemide ratio at 100mg/40mg Required wt loss is g/day without massive edema and g/day or more with massive edema Oral furosemide is preferred over iv furosemide.

Treatment of ascites of liver disease (continued) Do fluid restriction if sodium <120. Any of the following should lead to cessation of diuretics: - Encephalopathy -Serum NA <120 despite fluid restriction -Serum creatinine >2.0.

Treatment of large volume ascites Treatment of choice is large volume paracentesis: - Faster, more effective and fewer adverse effects than diuresis - Diuretics should be given as maintenance therapy to prevent recurrence

Refractory Ascites in liver disease <10% of ascites Defined as fluid overload that: 1)Is unresponsive to Na-restricted diet and high-dose diuretic treatment (400mg/day of spironolactone and 160mg/day of furosemide) OR 2) Recurs rapidly after therapeutic paracentesis.

Treatment of refractory ascites in liver disease Options: 1)Serial therapeutic paracentesis 2)Liver transplantation 3)Transjugular intrahepatic portasystemic stent-shunt (TIPS) 4)Peritoneovenous shunt (rarely done) Referal for liver transplant should not be delayed.

Complications of cirrhosis Variceal hemorrhage Ascites Spontaneous bacterial peritonitis Hepatorenal syndrome Hepatic encephalopahty Hepatopulmonary syndrome Hepatocellular carcinoma

All patients with chronic liver disease should be checked for hepatitis viral panel, especially for hepatits B and C. Vaccination should be given for hepatitis A and B vaccination if they are negative for these types of hepatitis.

The liver is commonly imaged (usually with Ultrasound) in a patient with cirrhosis with or without ascites. Why?

To screen for: -Hepatocellular carcinoma -Portal vein thrombosis -Hepatic vein thrombosis

Case 55 yo man with h/o heavy ETOH use presents with abdominal swelling and pain What other questions would you ask the patient? What are you looking for on your exam?

Case AST 150, ALT 73, alk phos 153, GGT 320 Bilirubin 4.3, Indirect bilirubin 3.1 TP 8.3 Albumin 2.2 INR 1.9 WBC 2.2, H/H 11/33. Plt 78K Na 130

What would you do first in the evaluation of this patient??

Paracentesis What information do you get from peritoneal fluid analysis? What studies do you want to perform on the ascites fluid?

Ascitic fluid Cloudy fluid Albumin 0.5 TP 0.7 Cell count: 425 WBC, 90% PMN’s Gram stain: many PMN’s, no bacteria

How do you interpret the results from your tap?

How will you treat the ascites?